Human C4d(Complement Component 4d) ELISA Kit

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Complement Component 4d (C4d) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Description: A sandwich ELISA kit for detection of Complement Component 4d from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d)

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d)

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Complement Component 4d (C4d) in serum, plasma and other biological fluids.

Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of High Sensitive Human Complement Component 4d (C4d) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with APC.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with Biotin.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with Cy3.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with FITC.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with HRP.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with PE.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with APC.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with Biotin.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with Cy3.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with FITC.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with HRP.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with PE.

Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This mAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: This antibody is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound protein. C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of antibodies to specific target molecules. Following activation and degradation of the C4 molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product C4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. C4d has been shown to be a significant predictor of transplant kidney graft survival. C4d antibody, combined with antibody to C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

Description: Quantitativesandwich ELISA kit for measuring Human Complement Fragment 4d, C4d in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Description: Quantitativesandwich ELISA kit for measuring Human Complement Fragment 4d, C4d in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.375 ng/ml

Description: A competitive ELISA for quantitative measurement of Human Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Human Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Human Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A Mouse monoclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with APC-Cy7.

Description: A Rabbit polyclonal antibody against Human Complement Component 4d (C4d). This antibody is labeled with APC-Cy7.

Description: A competitive ELISA for quantitative measurement of Goat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Goat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Goat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rabbit Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rabbit Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rabbit Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Porcine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Porcine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Porcine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Monkey Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Monkey Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Monkey Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Canine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Canine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Canine Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Rat Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Mouse Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Mouse Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Mouse Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A sandwich ELISA kit for quantitative measurement of Human C4d (Complement Fragment 4d) in samples from Serum, Plasma, Cell supernatant

Description: A competitive ELISA for quantitative measurement of Guinea pig Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Guinea pig Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: A competitive ELISA for quantitative measurement of Guinea pig Complement Fragment 4d,C4d in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Description: TW-4D with 11 in. Canister

Description: Mouse Monoclonal Complement 4d (C4d) (Acute Humoral Rejection Marker) Antibody. Validated in IF, IHC and tested in Human.

Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated

Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use)

Description: A Monoclonal antibody against Human Complement 4d (C4d) (Acute Humoral Rejection Marker). The antibodies are raised in Mouse and are from clone C4D204. This antibody is applicable in IHC-P, IF

Description: A Monoclonal antibody against Human Complement 4d (C4d) (Acute Humoral Rejection Marker). The antibodies are raised in Mouse and are from clone SPM545. This antibody is applicable in IHC-P, IF, E

Description: Primary antibody against Complement C4d(C4203), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF405S conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), PerCP conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), RPE conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF594 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), APC conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF680R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4203), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4D204), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4D204), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4D205), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4D205), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(TDM16), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(TDM16), Concentration: 0.2mg/mL

Description: Primary antibody against Complement C4d(C4203), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF488A conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), Biotin conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF568 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF647 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF543 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF660R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF680 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF405M conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D205), CF640R conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(TDM16), CF770 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4203), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF555 conjugate, Concentration: 0.1mg/mL

Description: Primary antibody against Complement C4d(C4D204), CF555 conjugate, Concentration: 0.1mg/mL